1 year return (CAGR)
-56.31%
Estrella Immunopharma Inc. Exchange (NASDAQ, USD)
ESLA
0.48
-0.02 (-3.39%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-61.83%
5 year return (CAGR)
-45.13%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
21.10M
Price/Sales
-
Ent value
30.21M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.56 |
| Daily high | 0.56 |
| Daily low | 0.48 |
| Daily Volume | 62K |
| All-time high | 21.25 |
| 1y analyst estimate | 12.00 |
| Beta | 0.89 |
| EPS (TTM) | -0.23 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ESLA | S&P500 | |
| Current price drop from All-time high | -97.72% | -0.58% |
| Highest price drop | -97.72% | -56.47% |
| Date of highest drop | 22 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -57.81% | -10.68% |
| Avg time to new high | 21 days | 12 days |
| Max time to new high | 766 days | 1805 days |
News
